CAS 115956-12-2
:Dolasetron
Descrizione:
Dolasetron is an antagonist of the serotonin (5-HT) receptor subtype 5-HT
3
(K
i
= 20 nM).
1
It is selective for 5-HT
3
receptors over 5-HT
1A
, 5-HT
1B
, 5-HT
2
, dopamine D
2
, α
1
-, α
2
-, β-adrenergic, M
1-5
muscarinic acetylcholine, and neurokinin-1 (NK
1
) receptors (IC
50
s = >10 μM for all).
2
Dolasetron inhibits 5-HT-induced membrane currents in NG 108-15 cells (IC
50
= 3.8 nM).
1
It increases the latency to emesis and reduces the number of vomiting and retching episodes induced by cisplatin (Item No.
13119
) in ferrets when administered at doses of 0.5 or 2 mg/kg.
2
Formulations containing dolasetron have been used in the prevention of postoperative or chemotherapy-induced nausea.
Formula:C19H20N2O3
InChI:InChI=1/C19H20N2O3/c22-17-10-21-13-5-12(17)6-14(21)8-15(7-13)24-19(23)18-16-4-2-1-3-11(16)9-20-18/h1-4,12-15H,5-10H2
InChI key:InChIKey=UKTAZPQNNNJVKR-MMUVGSQPNA-N
SMILES:O(C(=O)C=1C=2C(NC1)=CC=CC2)[C@@H]3C[C@]4([N@]5[C@](CC(C4)C(=O)C5)(C3)[H])[H]
Sinonimi:- (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate
- (6R)-3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aβ)-
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer
- 1H-indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- 2,6-Methano-2H-quinolizine, 1H-indole-3-carboxylic acid deriv.
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-isoindole-3-carboxylate
- Anemet
- Mdl 73147
- Dolasetron
- 1H-Indole-3-carboxylicacid, octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl ester, stereoisoMer
- Dolasteron
- Unii-82wi2L7Q6e
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2alpha,6alpha,8alpha,9abeta)-
- Octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl Ester
- rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic Acid 3-Oxooctahydro-2H-2,6-methanoquinolizin-8-yl Ester
- Hsdb 7565
- dolasetron USP/EP/BP
- Dolasetronum [inn-latin]
- (2a,6a,8a,9ab)-1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- Dolasetronum
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 12 prodotti.
Dolasetron
CAS:rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylateFormula:C19H20N2O3Purezza:98%Peso molecolare:324.371H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer
CAS:Formula:C19H20N2O3Purezza:98%Colore e forma:SolidPeso molecolare:324.3737Dolasetron-d4 (Indole-d4)
CAS:Formula:C19H16D4N2O3Colore e forma:Off-White SolidPeso molecolare:328.40Ref: 4Z-D-097012
5mgPrezzo su richiesta100mgPrezzo su richiesta10mg1.429,00€25mg2.620,00€50mg4.108,00€Dolasetron
CAS:Formula:C19H20N2O3Purezza:>98.0%(HPLC)Colore e forma:White to Almost white powder to crystalinePeso molecolare:324.38Dolasetron
CAS:Dolasetron (MDL-73147)(MDL-73147) is a serotonin 5-HT3 receptor antagonist. Dolasetron is used to treat nausea and vomiting following chemotherapy.Formula:C19H20N2O3Purezza:99.84% - 99.86%Colore e forma:White PowderPeso molecolare:324.37Dolasetron
CAS:Prodotto controllatoApplications Bridged pseudopelletierine derivative; specific serotonin (5HT3) receptor antagonist. Antiemetic.
References Boeijinga, P.H., et al.: Eur. J. Pharmacol., 219, 9 (1992), Miller, R.C., et al., Drug Dev. Res., 28, 87 (1993), Fauser, A.A., et al.: Eur. J. Cancer, 32, 1523 (1996), Graczyk, S.G., et al.: Anesth. Analg., 84, 325 (1997),Formula:C19H20N2O3Colore e forma:NeatPeso molecolare:324.37Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
CAS:Dolasetron mesylate is a mesylate of the biologically active form of dolasetron, which is an octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester. Dolasetron has been shown to be effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy or radiation therapy. It has been approved for use in adults with cancer who have not responded to other treatments. Dolasetron is rapidly absorbed from the gastrointestinal tract and is then distributed throughout the body, including into the brain. The elimination half life of dolasetron mesylate is about 2 hours and it binds to plasma proteins. Dolasetron mesylate specifically binds to serotonin receptors, which are found on cells in the gut. This binding inhibits serotonin induced contraction of bowel smooth muscle cells.Formula:C19H20N2O3Purezza:Min. 95%Colore e forma:White To Off-White To Grey SolidPeso molecolare:324.37 g/molRef: ST-EA-CP-D39000
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta









